SEARCH

SEARCH BY CITATION

References

  • Adler, A., Park, Y.D., Larsen, P., Nagarajan, V., Wollenberg, K., Qiu, J., et al. (2011) A novel specificity protein 1 (SP1)-like gene regulating protein kinase C-1 (Pkc1)-dependent cell wall integrity and virulence factors in Cryptococcus neoformans. J Biol Chem 286: 2097720990.
  • Barker, K.S., Pearson, M.M., and Rogers, P.D. (2003) Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. J Antimicrob Chemother 51: 11311140.
  • Barluzzi, R., Saleppico, S., Nocentini, A., Boelaert, J.R., Neglia, R., Bistoni, F., and Blasi, E. (2002) Iron overload exacerbates experimental meningoencephalitis by Cryptococcus neoformans. J Neuroimmunol 132: 140146.
  • Belay, T., Cherniak, R., Kozel, T.R., and Casadevall, A. (1997) Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun 65: 718728.
  • Bicanic, T., Meintjes, G., Wood, R., Hayes, M., Rebe, K., Bekker, L.G., and Harrison, T. (2007) Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 45: 7680.
  • Bicanic, T., Wood, R., Meintjes, G., Rebe, K., Brouwer, A., Loyse, A., et al. (2008) High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis 47: 123130.
  • Bicanic, T., Brouwer, A.E., Meintjes, G., Rebe, K., Limmathurotsakul, D., Chierakul, W., et al. (2009) Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 23: 701706.
  • Burchard, W., Schmidt, M., and Stockmayer, W.H. (1980) Information on polydispersity and branching from combined quasi-elastic and intergrated scattering. Macromolecules 13: 12651272.
  • Casadevall, A., Mukherjee, J., and Scharff, M.D. (1992) Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods 154: 2735.
  • Chang, Y., and Kwon-Chung, K. (1994) Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores virulence. Mol Cell Biol 14: 49124919.
  • Charlier, C., Chretien, F., Baudrimont, M., Mordelet, E., Lortholary, O., and Dromer, F. (2005) Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166: 421432.
  • Cherniak, R., Valafar, H., Morris, L., and Valafar, F. (1998) Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5: 146159.
  • Choi, J.N., Kim, J., Kim, J., Jung, W.H., and Lee, C.H. (2012) Influence of iron regulation on the metabolome of Cryptococcus neoformans. PLoS ONE 7: e41654.
  • Cordero, R.J., Frases, S., Guimaraes, A.J., Rivera, J., and Casadevall, A. (2011) Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol Microbiol 79: 11011117.
  • Doering, T.L. (2009) How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol 63: 223247.
  • Dromer, F., Mathoulin-Pelissier, S., Launay, O., and Lortholary, O. (2007) Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 4: e21.
  • Fonseca, F.L., Nohara, L.L., Cordero, R.J., Frases, S., Casadevall, A., Almeida, I.C., et al. (2010) Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter. Infect Immun 78: 38613870.
  • Frases, S., Nimrichter, L., Viana, N.B., Nakouzi, A., and Casadevall, A. (2008) Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell 7: 319327.
  • Frases, S., Pontes, B., Nimrichter, L., Viana, N.B., Rodrigues, M.L., and Casadevall, A. (2009) Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc Natl Acad Sci USA 106: 12281233.
  • Fries, B.C., Taborda, C.P., Serfass, E., and Casadevall, A. (2001) Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 108: 16391648.
  • Fries, B.C., Lee, S.C., Kennan, R., Zhao, W., Casadevall, A., and Goldman, D.L. (2005) Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun 73: 17791787.
  • Gates, M.A., and Kozel, T.R. (2006) Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans. Infect Immun 74: 30963106.
  • Goldman, D.L., Casadevall, A., and Zuckier, L.S. (1997) Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy. J Med Vet Mycol 35: 271278.
  • Granger, D.L., Perfect, J.R., and Durack, D.T. (1985) Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest 76: 508516.
  • Graybill, J.R., Sobel, J., Saag, M., van Der Horst, C., Powderly, W., Cloud, G., et al. (2000) Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 30: 4754.
  • Guerrero, A., and Fries, B.C. (2008) Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response. Infect Immun 76: 43224331.
  • Guerrero, A., Jain, N., Wang, X., and Fries, B.C. (2010) Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation. Infect Immun 78: 10491057.
  • Guimaraes, A.J., Frases, S., Cordero, R.J., Nimrichter, L., Casadevall, A., and Nosanchuk, J.D. (2010) Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo. Cell Microbiol 12: 740753.
  • Haynes, B.C., Skowyra, M.L., Spencer, S.J., Gish, S.R., Williams, M., Held, E.P., et al. (2011) Toward an integrated model of capsule regulation in Cryptococcus neoformans. PLoS Pathog 7: e1002411.
  • Imwidthaya, P., and Poungvarin, N. (2000) Cryptococcosis in AIDS. Postgrad Med J 76: 8588.
  • Jain, N., Cook, E., Xess, I., Hasan, F., Fries, D., and Fries, B.C. (2009a) Isolation and characterization of senescent C. neoformans and its implications for phenotypic switching and the pathogenesis of chronic cryptococcosis. Eukaryot Cell 8: 858866.
  • Jain, N., Li, L., Hsueh, Y.P., Guerrero, A., Heitman, J., Goldman, D.L., and Fries, B.C. (2009b) Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans. Infect Immun 77: 128140.
  • Jung, W.H., Sham, A., White, R., and Kronstad, J.W. (2006) Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol 4: e410.
  • Jung, W.H., Saikia, S., Hu, G., Wang, J., Fung, C.K., D'Souza, C., et al. (2010) HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans. PLoS Pathog 6: e1001209.
  • Kambugu, A., Meya, D.B., Rhein, J., O'Brien, M., Janoff, E.N., Ronald, A.R., et al. (2008) Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 46: 16941701.
  • Lian, T., Simmer, M.I., D'Souza, C.A., Steen, B.R., Zuyderduyn, S.D., Jones, S.J., et al. (2005) Iron-regulated transcription and capsule formation in the fungal pathogen Cryptococcus neoformans. Mol Microbiol 55: 14521472.
  • McClelland, E.E., Bernhardt, P., and Casadevall, A. (2005) Coping with multiple virulence factors: which is most important? PLoS Pathog 1: e40.
  • McFadden, D.C., De Jesus, M., and Casadevall, A. (2006) The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J Biol Chem 281: 18681875.
  • McFadden, D.C., Fries, B.C., Wang, F., and Casadevall, A. (2007) Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell 6: 14641473.
  • Nimrichter, L., Frases, S., Cinelli, L.P., Viana, N.B., Nakouzi, A., Travassos, L.R., et al. (2007) Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell 6: 14001410.
  • Nyhus, K.J., Wilborn, A.T., and Jacobson, E.S. (1997) Ferric iron reduction by Cryptococcus neoformans. Infect Immun 65: 434438.
  • Oliveira, D.L., Nimrichter, L., Miranda, K., Frases, S., Faull, K.F., Casadevall, A., and Rodrigues, M.L. (2009) Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. Fungal Genet Biol 46: 956963.
  • Ory, J.J., Griffith, C.L., and Doering, T.L. (2004) An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter. Yeast 21: 919926.
  • Park, B.J., Wannemuehler, K.A., Marston, B.J., Govender, N., Pappas, P.G., and Chiller, T.M. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525530.
  • Perfect, J.R., Lang, S.D., and Durack, D.T. (1980) Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol 101: 177194.
  • Pirofski, L.A., and Casadevall, A. (2008) The damage-response framework of microbial pathogenesis and infectious diseases. Adv Exp Med Biol 635: 135146.
  • Rodrigues, M.L., Nimrichter, L., Oliveira, D.L., Frases, S., Miranda, K., Zaragoza, O., et al. (2007) Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 6: 4859.
  • Rodrigues, M.L., Nakayasu, E.S., Oliveira, D.L., Nimrichter, L., Nosanchuk, J.D., Almeida, I.C., and Casadevall, A. (2008) Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell 7: 5867.
  • Seaton, R.A., Naraqi, S., Wembri, J.P., and Warrell, D.A. (1996) Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. QJM 89: 423428.
  • Yoneda, A., and Doering, T.L. (2008) Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot Cell 7: 546549.
  • Zaragoza, O., Rodrigues, M.L., De Jesus, M., Frases, S., Dadachova, E., and Casadevall, A. (2009) The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol 68: 133216.